Lilly to boost Indianapolis manufacturing site with $400m injection, 100 jobs to be created
Eli Lilly is poised to boost its manufacturing capacity with the investment of $400 million at its Lilly Technology Center campus in Indianapolis, the company announced, in a move to step up to increasing demand for its medicines.
According to the company, this investment will create around 100 new “highly skilled” positions at the site, as well as deliver enhancements to its insulin-producing manufacturing facilities.
Read more...